Consider New Options When a Potassium Binder Is Needed for Chronic Hyperkalemia

New Lokelma (loh-KEL-mah) and Veltassa (vel-TAS-sah) will pique interest in potassium binders to manage CHRONIC hyperkalemia.

Both Lokelma and Veltassa will be coming in early 2020.

There's interest in using these meds to help patients with high potassium stay on an ACEI, ARB, or aldosterone antagonist. This is especially helpful when they're needed for chronic kidney disease, heart failure with reduced ejection fraction, resistant hypertension, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote